Indole-3-carbinol - Induced growth inhibition can be converted to a cytotoxic response in the presence of TPA + Ca2+ in squamous cell carcinoma cell lines

FEBS Letters

Volumn 581, Issue 20, 2007, Pages 3839-3847

  Dahler, A L ^a   Rickwood, D ^a   Guminski, A ^a,b   Teakle, N ^a   Saunders, N A ^a,b,c  

^a Diamantina Institute for Cancer   (Australia)

^b Queensland Centre for Mental Health Research   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Indole 3 carbinol; Keratinocyte; Squamous cell carcinoma; Squamous differentiation

Indexed keywords

3 INDOLEMETHANOL; CALCIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR; CALCIUM; INDOLE DERIVATIVE; INDOLE-3-CARBINOL; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PRIORITY JOURNAL; SENESCENCE; SQUAMOUS CELL CARCINOMA; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; EPITHELIUM CELL; FLOW CYTOMETRY; GROWTH; KERATINOCYTE; MALE; NEWBORN; PATHOLOGY; SKIN; TIME;

CALCIUM; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EPITHELIAL CELLS; FLOW CYTOMETRY; GROWTH; HUMANS; INDOLES; INFANT, NEWBORN; KERATINOCYTES; MALE; SKIN; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 34548618192     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.07.009     Document Type: Article

References (31)

1. Saunders N.A., Smith R.J., and Jetten A.M. Expression of proliferation-specific and differentiation-specific genes in senescing human epithelial cells. Biochem. Biophys. Res. Commun. 197 (1993) 46-54
2. Saunders N.A., and Jetten A.M. Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon-γ. Antagonism by retinoic acid and transforming growth factor β1. J. Biol. Chem. 269 (1994) 2016-2022
3. Jones S.J., Dicker A.J., Dahler A.L., and Saunders N.A. E2F as a regulator of keratinocyte proliferation: implications for skin tumour development. J. Invest. Dermatol. 109 (1997) 187-193
4. Popa C., Dahler A.L., Serewko-Auret M.M., Wong C.F., Smith L., Barnes L.M., Strutton G.M., and Saunders N.A. AP-2 transcription factor family member expression, activity and regulation in human epidermal keratinocytes in vitro. Differentiation 72 5 (2004) 185-197
5. Eckert R.L., Crish J.F., and Robinson N.A. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol. Rev. 77 2 (1997) 397-424
6. Fuchs E., and Green H. Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 19 4 (1980) 1033-1042
7. Dicker A.J., Serewko M.M., Dahler A.L., Khanna K.K., Kaur P., Li A., Strutton G., and Saunders N.A. Functional characterisation of cultured cells derived from an intraepidermal carcinoma of the skin (IEC-1). Exp. Cell Res. 258 (2000) 352-360
8. Dicker A.J., Popa C., Dahler A.L., Serewko M.M., Hilditch-Maguire P.A., Frazer I.H., and Saunders N.A. E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytes. Oncogene 19 (2000) 2887-2894
9. Wong C.F., Barnes L.M., Dahler A.L., Smith L., Serewko-Auret M.M., Popa C., Jabbar I.A., and Saunders N.A. A role for E2F in the modulation of keratinocyte squamous differentiation: implications for the use of an E2F inhibitor in squamous cell carcinoma. J. Biol. Chem. 278 31 (2003) 28516-28522
10. Wong C.F., Barnes L.M., Smith L., Popa C., Serewko-Auret M.M., and Saunders N.A. E2F6, a member of the E2F family that does not modulate squamous differentiation. Biochem. Biophys. Res. Commun. 324 (2004) 497-503
11. Wong C.F., Barnes L.M., Dahler A.L., Smith L., Popa C., Serewko-Auret M.M., and Saunders N.A. Sp1 is a downstream effector of E2F-mediated suppression of squamous differentiation. Oncogene 24 (2005) 3525-3534
12. Wong C.F., Guminski A., Saunders N.A., and Burgess A.J. Exploiting novel cell cycle targets in the development of anticancer agents. Curr. Cancer Drug Targets 5 2 (2005) 85-102
13. Cover C.M., Hsieh S.J., Tran S.H., Hallden G., Kim G., Bjeldanes L.F., and Firestone G.L. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 arrest of human breast cancer cells independent of estrogen receptor signalling. J. Biol. Chem. 273 (1998) 3838-3847
14. Chinni S.R., Li Y., Upadhyay S., Koppolu P.K., and Sarkar F.H. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 20 (2001) 2927-2936
15. Aggarwal B.B., and Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 4 (2005) 1201-1215
16. INK4b gene. FEBS Lett. 576 (2004) 137-140
17. Kalish L.H., Kwong R.A., Cole R.E., Gallagher R.M., Sutherland R.L., and Musgrove E.A. Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines. Clin. Cancer Res. 10 (2004) 7764-7774
18. Brinkmann H., Dahler A.L., Popa C., Serewko M.M., Parsons P.G., Gabrielli B.G., Burgess A.J., and Saunders N.A. Histone hyperacetylation induced by histone deacetylase inhibitors is not sufficient to cause growth inhibition in human dermal fibroblasts. J. Biol. Chem. 276 (2001) 22491-22499
19. Serewko M.M., Popa C., Dahler A.L., Smith L., Strutton G.M., Coman W., Dicker A.J., and Saunders N.A. Alterations in gene expression and activity during squamous cell carcinoma development. Cancer Res. 62 (2002) 3759-3765
20. Walshe J., Serewko-Auret M.M., Teakle N., Cameron S., Minto K., Smith L., Burcham P.C., Russell C.T., Strutton G., Griffin A., Chu F.F., Esworthy S., Reeve V.E., and Saunders N.A. Inactivation of glutathione peroxidise activity contributes to UV-induced squamous cell carcinoma formation. Cancer Res. 67 (2007) 4751-4758
21. Putral L.N., Bywater M.J., Gu W., Saunders N.A., Gabrielli B.G., Leggatt G.R., and McMillan N.A.J. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Mol. Pharmacol. 68 (2005) 1311-1319
22. Saunders N.A., Smith R.J., and Jetten A.M. Regulation of guanylate-binding protein expression in interferon-γ treated human epidermal keratinocytes and squamous cell carcinomas. J. Invest. Dermatol. 112 (1999) 977-983
23. Xue W., Zenedr L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., Cordon-Cardo C., and Lowe S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007) 656-660
24. Levine B. Autophagy and cancer. Nature 446 (2006) 745-747
25. Liu Z., and Lenardo M.J. Reactive oxygen species regulate autophagy through redox-sensitive proteases. Develop. Cell 12 (2007) 484-485
26. Zhu J.H., Horbinski C., Guo F., Watkins S., Uchiyama Y., and Chu C.T. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am. J. Pathol. 170 (2007) 16-19
27. Rahman K.M.W., Sarkar F.H., Banerjee S., Wang Z., Liao D.J., Hong X., and Sarkar N.H. Therapeutic intervention of experimental breast cancer metastasis by indole-3-carbinol in SCID-human mouse model. Mol. Cancer Ther. 5 (2006) 2747-2756
28. Rahman K.M., Aranha O., Glkazyrin A., Chinni S.R., and Farkar S.H. Translocation of Bax to mitochondria induces apoptotic cell death in indole-3-carbinol (I3C) treated breast cancer cells. Oncogene 19 (2000) 5764-5771
29. Moiseeva E.P., Heukers R., and Manson M.M. EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells. Carcinogenesis 28 (2007) 435-445
30. Kurosus T., Tsuji K., Kida A., Koyama T., Yamamoto M., and Miura O. Rottlerin synergistically enhances imatinib-induced apoptosis of BCR/ABL-expressing cells through its mitochondrial uncoupling effect independent of protein kinase C-δ. Oncogene 26 (2007) 2975-2987
31. Hamada M., Sumi T., Iwai S., Nakazawa M., and Yura Y. Induction of endonuclease G-mediated apopotosis in human oral squamous cell carcinoma cells by protein kinase C inhibitor safingol. Cancer Res. 11 (2006) 47-56